Market Cap 1.56M
Revenue (ttm) 0.00
Net Income (ttm) -26.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 46,300
Avg Vol 373,624
Day's Range N/A - N/A
Shares Out 929,000.00
Stochastic %K 47%
Beta 0.61
Analysts Sell
Price Target $30.00

Company Profile

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 3 933 3121
Fax: 972 3 509 7196
Address:
4 Oppenheimer Street, Science Park, Rehovot, Israel
Winorbust
Winorbust Jun. 28 at 4:11 PM
$PPBT put it this way, retail was scammed, lied to, and used as an ATM for management to keep the lights on and their insane salaries continuing. And the pumpers in this stock helped them!
0 · Reply
Purplepayday
Purplepayday Jun. 28 at 11:56 AM
$PPBT .. Yes, it looks like we have some muddy waters to go through… 👇
0 · Reply
Purplepayday
Purplepayday Jun. 28 at 10:32 AM
$PPBT Because of the company’s distressed financial situation any deal is not going to be ”HUGE” Here is a realistic assumption for a license-deal for each assets…. And bear in mind that NT219 have to pay back around $10M to Yissum, Birad and the israel state if it’s taken out of Israel. Yes, there’s also some other payment’s for CM24 that have to be reimbursed to TMH.
4 · Reply
Purplepayday
Purplepayday Jun. 27 at 9:02 AM
$PPBT Shareholders vote here will have no impact on anything if management needs approval! Purple Biotech Ltd. is authorized to issue up to 50,000,000 non-voting senior preferred shares without shareholder approval. - And the board has the authority to set the conversion terms at the exact time of issuance.
0 · Reply
Purplepayday
Purplepayday Jun. 27 at 8:09 AM
$PPBT Current Status: As of late June 2026, the lawsuit remains ongoing and unresolved. Purple Biotech continues to formally reject all allegations made by the Atzmon Plaintiffs.
1 · Reply
BitterTwit2
BitterTwit2 Jun. 26 at 1:51 PM
$PPBT We're going to the moon... 🚀
0 · Reply
JuggernautRaider
JuggernautRaider Jun. 26 at 12:32 PM
$NEXR $PRZO $PPBT $DFNS warned you all 😠 😤 😡
0 · Reply
Purplepayday
Purplepayday Jun. 25 at 7:22 PM
$PPBT Only 39 days left….. 👍 D. Property, Plant and Equipment All of our facilities are leased, and we do not own any real property. The principal executive offices for Purple Biotech, TyrNovo, FameWave and Immunorizon are in a commercial office building located in the Science Park in Rehovot, Israel. On July 27, 2025, we signed an amendment to our existing lease agreement for this office The agreement extends the lease term by 12 months, running from January 1, 2026, through December 31, 2026. Additionally, we were granted an option to extend the lease for another 48 months, potentially continuing the term until December 31, 2030. This option renews automatically unless we provide written notice of our intent not to renew at least 150 days before the end of the 2026 extension. We have no material tangible fixed assets apart from the property described above. We believe our facilities are adequate and suitable for our current needs.
2 · Reply
coinspitter
coinspitter Jun. 25 at 3:45 PM
$PPBT Buying more buyout lottery tickets. Best to have no concrete expectations on a timeline though.
1 · Reply
Winorbust
Winorbust Jun. 25 at 3:17 PM
$PPBT would you agree that the bulls like Smitty, Brad, Dr. Him and others led people to the slaughter and convinced others to ignore the bears, when the bears were in fact right about everything?
1 · Reply
Latest News on PPBT
Purple Biotech presents new IM1240 data at EACR

2026-06-11T12:12:56.000Z - 18 days ago

Purple Biotech presents new IM1240 data at EACR


Purple Biotech files $200M mixed securities shelf

2026-05-20T21:35:38.000Z - 5 weeks ago

Purple Biotech files $200M mixed securities shelf


Purple Biotech announces collaboration with Converge Bio

2026-03-25T12:17:12.000Z - 3 months ago

Purple Biotech announces collaboration with Converge Bio


Purple Biotech regains compliance with Nasdaq

2026-03-17T11:31:37.000Z - 3 months ago

Purple Biotech regains compliance with Nasdaq


Purple Biotech CEO Gil Efron to step down in August

2026-03-13T12:13:32.000Z - 3 months ago

Purple Biotech CEO Gil Efron to step down in August


Purple Biotech reports Q4 EPS ($19.85) vs. ($2.00) last year

2026-03-13T12:07:41.000Z - 3 months ago

Purple Biotech reports Q4 EPS ($19.85) vs. ($2.00) last year


Purple Biotech Announces CEO Transition

Fri, 13 Mar 2026 08:04:00 -0400 - 3 months ago

Purple Biotech Announces CEO Transition


Purple Biotech trading halted, news pending

2026-02-28T00:50:34.000Z - 4 months ago

Purple Biotech trading halted, news pending


Purple Biotech to implement ADS ratio change

2026-02-25T22:35:50.000Z - 4 months ago

Purple Biotech to implement ADS ratio change


Purple Biotech Announces Plan to Implement ADS Ratio Change

Wed, 25 Feb 2026 16:20:00 -0500 - 4 months ago

Purple Biotech Announces Plan to Implement ADS Ratio Change


Purple Biotech completes toxicology study of IM1240

2026-01-07T13:05:42.000Z - 6 months ago

Purple Biotech completes toxicology study of IM1240


Purple Biotech’s antibody platform shows anti-tumor activity

2025-12-11T12:26:28.000Z - 7 months ago

Purple Biotech’s antibody platform shows anti-tumor activity


Purple Biotech reports Q3 EPS (29c) vs. (39c) last year

2025-11-14T13:11:08.000Z - 8 months ago

Purple Biotech reports Q3 EPS (29c) vs. (39c) last year


Purple Biotech sees cash runway into 1H27

2025-11-14T13:10:49.000Z - 8 months ago

Purple Biotech sees cash runway into 1H27


Why Is Purple Biotech Stock (PPBT) Up 95% Today?

2025-10-29T13:21:27.000Z - 8 months ago

Why Is Purple Biotech Stock (PPBT) Up 95% Today?


Purple Biotech achieves manufacturing milestone for IM1240

2025-10-29T11:41:23.000Z - 8 months ago

Purple Biotech achieves manufacturing milestone for IM1240


Purple Biotech receives noncompliance notification from Nasdaq

2025-10-20T20:05:22.000Z - 8 months ago

Purple Biotech receives noncompliance notification from Nasdaq


Purple Biotech prices 5.99M ADSs at $1.00 in public offering

2025-09-04T13:20:09.000Z - 10 months ago

Purple Biotech prices 5.99M ADSs at $1.00 in public offering


Purple Biotech announces new data on IM1240

2025-09-04T11:20:09.000Z - 10 months ago

Purple Biotech announces new data on IM1240

PPBT


Purple Biotech expands CAPTN-3 portfolio with IM1305

2025-09-03T11:06:00.000Z - 10 months ago

Purple Biotech expands CAPTN-3 portfolio with IM1305

PPBT


Purple Biotech reports Q2 EPS 40c vs $1.80 last year

2025-08-06T11:21:25.000Z - 11 months ago

Purple Biotech reports Q2 EPS 40c vs $1.80 last year

PPBT


Purple Biotech Reports Second Quarter 2025 Financial Results

Aug 6, 2025, 7:00 AM EDT - 11 months ago

Purple Biotech Reports Second Quarter 2025 Financial Results


Purple Biotech Reports First Quarter 2025 Financial Results

May 21, 2025, 7:10 AM EDT - 1 year ago

Purple Biotech Reports First Quarter 2025 Financial Results


Why Is Purple Biotech Stock Trading Higher On Monday?

Dec 2, 2024, 9:18 AM EST - 1 year ago

Why Is Purple Biotech Stock Trading Higher On Monday?


Purple Biotech Reports Third Quarter 2024 Financial Results

Nov 15, 2024, 7:00 AM EST - 1 year ago

Purple Biotech Reports Third Quarter 2024 Financial Results


Purple Biotech Reports First Quarter 2024 Financial Results

May 21, 2024, 7:30 AM EDT - 2 years ago

Purple Biotech Reports First Quarter 2024 Financial Results


Purple Biotech Reaches Recommended Phase 2 Dose for NT219

Feb 1, 2024, 7:30 AM EST - 2 years ago

Purple Biotech Reaches Recommended Phase 2 Dose for NT219


Purple Biotech Reports Third Quarter 2023 Financial Results

Nov 21, 2023, 6:50 AM EST - 2 years ago

Purple Biotech Reports Third Quarter 2023 Financial Results


Purple Biotech Announces $5 Million Registered Direct Offering

Oct 17, 2023, 8:00 AM EDT - 2 years ago

Purple Biotech Announces $5 Million Registered Direct Offering


Purple Biotech Reports Second Quarter 2023 Financial Results

Aug 22, 2023, 9:29 AM EDT - 3 years ago

Purple Biotech Reports Second Quarter 2023 Financial Results


Winorbust
Winorbust Jun. 28 at 4:11 PM
$PPBT put it this way, retail was scammed, lied to, and used as an ATM for management to keep the lights on and their insane salaries continuing. And the pumpers in this stock helped them!
0 · Reply
Purplepayday
Purplepayday Jun. 28 at 11:56 AM
$PPBT .. Yes, it looks like we have some muddy waters to go through… 👇
0 · Reply
Purplepayday
Purplepayday Jun. 28 at 10:32 AM
$PPBT Because of the company’s distressed financial situation any deal is not going to be ”HUGE” Here is a realistic assumption for a license-deal for each assets…. And bear in mind that NT219 have to pay back around $10M to Yissum, Birad and the israel state if it’s taken out of Israel. Yes, there’s also some other payment’s for CM24 that have to be reimbursed to TMH.
4 · Reply
Purplepayday
Purplepayday Jun. 27 at 9:02 AM
$PPBT Shareholders vote here will have no impact on anything if management needs approval! Purple Biotech Ltd. is authorized to issue up to 50,000,000 non-voting senior preferred shares without shareholder approval. - And the board has the authority to set the conversion terms at the exact time of issuance.
0 · Reply
Purplepayday
Purplepayday Jun. 27 at 8:09 AM
$PPBT Current Status: As of late June 2026, the lawsuit remains ongoing and unresolved. Purple Biotech continues to formally reject all allegations made by the Atzmon Plaintiffs.
1 · Reply
BitterTwit2
BitterTwit2 Jun. 26 at 1:51 PM
$PPBT We're going to the moon... 🚀
0 · Reply
JuggernautRaider
JuggernautRaider Jun. 26 at 12:32 PM
$NEXR $PRZO $PPBT $DFNS warned you all 😠 😤 😡
0 · Reply
Purplepayday
Purplepayday Jun. 25 at 7:22 PM
$PPBT Only 39 days left….. 👍 D. Property, Plant and Equipment All of our facilities are leased, and we do not own any real property. The principal executive offices for Purple Biotech, TyrNovo, FameWave and Immunorizon are in a commercial office building located in the Science Park in Rehovot, Israel. On July 27, 2025, we signed an amendment to our existing lease agreement for this office The agreement extends the lease term by 12 months, running from January 1, 2026, through December 31, 2026. Additionally, we were granted an option to extend the lease for another 48 months, potentially continuing the term until December 31, 2030. This option renews automatically unless we provide written notice of our intent not to renew at least 150 days before the end of the 2026 extension. We have no material tangible fixed assets apart from the property described above. We believe our facilities are adequate and suitable for our current needs.
2 · Reply
coinspitter
coinspitter Jun. 25 at 3:45 PM
$PPBT Buying more buyout lottery tickets. Best to have no concrete expectations on a timeline though.
1 · Reply
Winorbust
Winorbust Jun. 25 at 3:17 PM
$PPBT would you agree that the bulls like Smitty, Brad, Dr. Him and others led people to the slaughter and convinced others to ignore the bears, when the bears were in fact right about everything?
1 · Reply
Pegasus_13
Pegasus_13 Jun. 25 at 3:00 PM
$PPBT j..sh pos. I am out with 89% loss. Tired of looking at this ticker and monitoring this garbage.
1 · Reply
coinspitter
coinspitter Jun. 25 at 7:45 AM
$PPBT buyout/asset sale is more likely.
1 · Reply
tondapacanda
tondapacanda Jun. 25 at 5:59 AM
$PPBT lets see how we are doing....another reverse split around the corner? great, I have survived 5 rounds already and I am down 99.3 percent :). This company is fraudulent piece of shit so please stay away from it.
0 · Reply
coinspitter
coinspitter Jun. 24 at 6:39 PM
$PPBT CEO departure end of August and we shall find out why they need no replacement 😅
1 · Reply
Jay_tradr
Jay_tradr Jun. 24 at 6:27 PM
$PPBT finally bit the bullet and sold my position here after 6 years. 99.95% losses. All set looking at this shit in my account anymore.
3 · Reply
Purplepayday
Purplepayday Jun. 24 at 6:11 PM
$PPBT I think that the management know exactly what they was doing when they made the $200 million ATM 🧐
0 · Reply
Purplepayday
Purplepayday Jun. 24 at 5:02 PM
$PPBT This could also be the explanation for the high dilution on the 11th June 🤷🏻‍♂️ Which then means that they have used all of the BABY shelf … And now only have the 1.2 million warrants left to lower the exercise price on 🧐 👇 Under SEC Rule I.B.6, companies with a public float below $75 million are restricted by a Baby Shelf rule, limiting share sales to 33.3% of their public float value within 12 months, based on the highest closing price over the previous 60 days. When the share price spiked to $5.96, the 60-day high calculation was triggered, temporarily increasing the company's valuation and allowing for the immediate dilution of 600K more shares and still be compliant with the rules.
2 · Reply
nebleros
nebleros Jun. 24 at 5:01 PM
$PPBT Come on Smitty post something, anything.. this silence is pure horror..
1 · Reply
Smittysixty
Smittysixty Jun. 23 at 9:07 PM
$PPBT ⬇️
1 · Reply
Smittysixty
Smittysixty Jun. 23 at 9:06 PM
$PPBT 👀 ⬇️
0 · Reply
Winorbust
Winorbust Jun. 23 at 8:16 PM
$DFNS $NEXR $NVCR $PPBT Jascar lost sooooo much money on PPBT it would be hilarious if it wasn’t so bad. But don’t forget Jascar also ignored and even blocked anyone who disagreed with him or tried warning him
0 · Reply
JuggernautRaider
JuggernautRaider Jun. 23 at 7:48 PM
$NEXR scams pay off once in awhile right @jascar ? Eh maybe not on $PPBT but mayne $NVCR or $DFNS will end up being “real” 🧠
0 · Reply